Meadow Creek Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $199K | Hold |
3,206
| – | – | ﹤0.01% | 1032 |
|
|
2019
Q2 | $228K | Buy |
3,206
+308
| +11% | +$21.9K | ﹤0.01% | 999 |
|
|
2019
Q1 | $227K | Hold |
2,898
| – | – | ﹤0.01% | 969 |
|
|
2018
Q4 | $245K | Hold |
2,898
| – | – | 0.01% | 892 |
|
|
2018
Q3 | $496K | Buy |
2,898
+77
| +3% | +$13.2K | 0.01% | 727 |
|
|
2018
Q2 | $365K | Hold |
2,821
| – | – | 0.01% | 787 |
|
|
2018
Q1 | $291K | Hold |
2,821
| – | – | 0.01% | 862 |
|
|
2017
Q4 | $241K | Buy |
2,821
+615
| +28% | +$52.5K | 0.01% | 929 |
|
|
2017
Q3 | $187K | Buy |
2,206
+436
| +25% | +$37K | ﹤0.01% | 938 |
|
|
2017
Q2 | $134K | Buy |
1,770
+821
| +87% | +$62.2K | ﹤0.01% | 994 |
|
|
2017
Q1 | $63K | Buy |
949
+180
| +23% | +$11.9K | ﹤0.01% | 1087 |
|
|
2016
Q4 | $49K | Buy |
+769
| New | +$49K | ﹤0.01% | 1125 |
|